These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3101286)

  • 21. [Changes in thrombocyte volume in thrombocyte concentrates prepared from blood preserved with ACD or CPD as anticoagulants].
    Flego I; Nazor A; Grgicević D; Lupret L; Marchiotti I
    Lijec Vjesn; 1988; 110(3-4):75-8. PubMed ID: 3398688
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative morphological study of erythrocytes in various types of whole blood and packed cell preparations stored in liquid state].
    Cazin P; Fabre G; Allary M; Saint-Blancard J
    Rev Fr Transfus Immunohematol; 1982 Oct; 25(5):499-512. PubMed ID: 7163730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of anticoagulants on the chromogenic Limulus lysate assay for endotoxin.
    McConnell JS; Cohen J
    J Clin Pathol; 1985 Apr; 38(4):430-2. PubMed ID: 3988956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of Na3-citrate on the solubility of cryoprecipitate (citrate effect on cryoprecipitate).
    Faludi E; Harsányi V
    Haematologia (Budap); 1981; 14(2):207-14. PubMed ID: 6792005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of factor VIII activity in cryoprecipitates prepared from ACD and CPD plasma.
    Shanberge JN; Gruhl MC; Ikemori R; Inoshita K; Chalos MK; Aster RH
    Transfusion; 1972; 12(4):251-8. PubMed ID: 5039460
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates.
    Farrugia A; Douglas S; James J; Whyte G; Herrington R
    Thromb Haemost; 1990 Nov; 64(3):374-8. PubMed ID: 2128967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the optimal anticoagulant solution for storage of whole blood samples prior to measurement of platelet-associated IgG.
    Gibbons S; Kelton JG
    Transfusion; 1982; 22(4):295-7. PubMed ID: 6808719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anticoagulants in vitro on the viability of lymphocytes and content of free fatty acids in plasma.
    Klein A; Ramcharitar S; Christeff N; Nisbett-Brown E; Nunez E; Malkin A
    In Vitro Cell Dev Biol; 1991 Apr; 27A(4):307-11. PubMed ID: 1856156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulation and function of human platelets isolated from units of CPDA-1, CPDA-2, and CPDA-3 anticoagulated blood and frozen with DMSO.
    Vecchione JJ; Melaragno AJ; Hollander A; Defina S; Emerson CP; Valeri CR
    Transfusion; 1982; 22(3):206-9. PubMed ID: 7090033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in cryoprecipitate production.
    Rock G; Tittley P
    Transfusion; 1977; 17(1):50-3. PubMed ID: 841673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of factor VIII recovery in cryoprecipitate.
    Kasper CK; Myhre BA; McDonald JD; Nakasako Y; Feinstein DI
    Transfusion; 1975; 15(4):312-22. PubMed ID: 1166504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severely heated therapeutic factor VIII concentrate of high specific activity.
    Winkelman L; Owen NE; Evans DR; Evans H; Haddon ME; Smith JK; Prince PJ; Williams JD; Lane RS
    Vox Sang; 1989; 57(2):97-103. PubMed ID: 2506696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin and factor VIII.
    Smit Sibinga CT; Das PC
    Scand J Haematol Suppl; 1984; 40():111-22. PubMed ID: 6433440
    [No Abstract]   [Full Text] [Related]  

  • 35. [The study of anticoagulants selection in platelet-rich plasma preparation].
    Hua L; Lai G; Zhenjun L; Guie M
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Jul; 31(4):295-300. PubMed ID: 26665933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of donor characteristics and preparation methods on the potency of human cryoprecipitate.
    Burka ER; Puffer T; Martinez J
    Transfusion; 1975; 15(4):323-8. PubMed ID: 1166505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
    Giraldo CE; Álvarez ME; Carmona JU
    BMC Vet Res; 2015 Mar; 11():60. PubMed ID: 25889052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of red cell antigens and plasma coagulation factors stored in new formulation plastic blood containers.
    Snyder EL; Hezzey A; Weirich F; Mosher DF; Davisson W; Buchholz DH
    Transfusion; 1983; 23(1):49-53. PubMed ID: 6829059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison studies of whole blood stored in ACD and CPD and with adenine. USAMRL Rep No 719.
    Shields CE; Camp FR
    Rep US Army Med Res Lab; 1967 Mar; ():1-12. PubMed ID: 5302574
    [No Abstract]   [Full Text] [Related]  

  • 40. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.